Thanks for that.
I just can't believe how much of a spotlight, Mesoblast is starting to get due to Covid-19.
Prior to Covid-19, MSC treatment would be a hard sell in an orphan designated product.
So unless you are a real specialist and/or have been touched by GVHD, it would be hard for anyone else to have heard of Mesoblast.
This publicity cannot be easily bought, and the snowball effect of this publicity will begin soon.
Forbes hey - who's next. Bring on more news
MSB Trading - 2020, page-7446
-
- There are more pages in this discussion • 15,715 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |